A recent clinical study with the GM1 ganglioside offers broad promise for the treatment of a variety of neurological diseases and disabilities (Chen, Y.-K., M.D., Tian, H.-Y., M.D., et al.)
Ganglioside FILE
FIM was established in 1976 by Stephen L. DeFelice, M.D. who coined the term nutraceutical. FIM is the leading advocate for encouraging natural substance medical research.